IEX •
Healthcare •
Biotechnology •
Quote as of 05/18/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization1,883.41 mln
Earnings Date08/25/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-0.7
Highly suspicious
1-Year Forecast
47.88
Transformational upside
Relative Strength
7
/ 100
Severely lagging
Debt / Equity
1.50
High leverage
ROE
-165
Deeply negative
Business Description
Founded in 2009 and based in Suzhou, China, Ascentage Pharma is a clinical-stage biopharmaceutical company focused on developing treatments for cancer, chronic hepatitis B, and age-related conditions. The company has built a broad pipeline of drug candidates that work by targeting specific proteins involved in tumor growth and cell survival, with several compounds designed to be taken orally to improve patient convenience. Beyond its research activities, Ascentage also engages in venture investment and technology services, and works alongside a network of pharmaceutical companies and research institutions to advance its programs toward commercialization.
